Products for Research Use Only
RegisterLogin

YL-109

CAT: 0804-HY-18619-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-18619-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
YL-109 is an antitumor agent that can induce carboxyl terminus of Hsp70-interacting protein (CHIP) expression through aryl hydrocarbon receptor (AhR) signaling. YL-109 has ability to inhibit breast cancer cell growth and invasiveness[1].
CAS Number
36341-25-0
UNSPSC
12352005
Hazard Statement
H315, H317, H318, H334, H335, H341, H361, H370, H413
Target
Aryl Hydrocarbon Receptor
Type
Reference compound
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/YL-109.html
Purity
99.26
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
OC1=CC=C(C2=NC3=CC=CC=C3S2)C=C1OC
Molecular Formula
C14H11NO2S
Molecular Weight
257.31
Precautions
H315, H317, H318, H334, H335, H341, H361, H370, H413
References & Citations
[1]Hiyoshi H, et al. 2- (4-Hydroxy-3-methoxyphenyl) -benzothiazole suppresses tumor progression and metastatic potential of breast cancer cells by inducing ubiquitin ligase CHIP. Sci Rep. 2014 Nov 18;4:7095.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-11046AKRP-109
HY-114116-01ML-109
HY-W423595-01BEBT-109
HY-118833RAC 109
HY-129603-01SI-109
HY-19643JTK-109
HY-15665-01XMD17-109
HY-162360EGFR-IN-109
HY-135307-01SSF-109
HY-147835Antibacterial agent 109

Alternative Products

CatalogName
B4857-5YL-109
A14421-200YL-109 200mg
A14421-50YL-109 50mg
A14421-25YL-109 25mg
A14421-5YL-109 5mg
A14421-500YL-109 500mg
A14421-100YL-109 100mg
A14421-10YL-109 10mg
A14421-2YL-109 2mg
A14421-10mM-DYL-109 10mM * 1mL in DMSO

Popular Products